429 related articles for article (PubMed ID: 30796154)
1. Comparison of the Clinicopathological Characteristics and Genetic Alterations Between Patients with Gastric Cancer with or Without
Fang WL; Huang KH; Chang SC; Lin CH; Chen MH; Chao Y; Lo SS; Li AF; Wu CW; Shyr YM
Oncologist; 2019 Sep; 24(9):e845-e853. PubMed ID: 30796154
[TBL] [Abstract][Full Text] [Related]
2. Mutations in PI3K/AKT pathway genes and amplifications of PIK3CA are associated with patterns of recurrence in gastric cancers.
Fang WL; Huang KH; Lan YT; Lin CH; Chang SC; Chen MH; Chao Y; Lin WC; Lo SS; Li AF; Wu CW; Chiou SH; Shyr YM
Oncotarget; 2016 Feb; 7(5):6201-20. PubMed ID: 26701847
[TBL] [Abstract][Full Text] [Related]
3. Occurrence of Helicobacter pylori and Epstein-Barr virus infection in endoscopic and gastric cancer patients from Northern Brazil.
de Souza CR; de Oliveira KS; Ferraz JJ; Leal MF; Calcagno DQ; Seabra AD; Khayat AS; Montenegro RC; Alves AP; Assumpção PP; Smith MC; Burbano RR
BMC Gastroenterol; 2014 Oct; 14():179. PubMed ID: 25318991
[TBL] [Abstract][Full Text] [Related]
4. Case–control study of Epstein–Barr virus and Helicobacter pylori serology in Latin American patients with gastric disease.
Cárdenas-Mondragón MG; Torres J; Flores-Luna L; Camorlinga-Ponce M; Carreón-Talavera R; Gomez-Delgado A; Kasamatsu E; Fuentes-Pananá EM
Br J Cancer; 2015 Jun; 112(12):1866-73. PubMed ID: 25996206
[TBL] [Abstract][Full Text] [Related]
5. Alterations in the human epidermal growth factor receptor 2-phosphatidylinositol 3-kinase-v-Akt pathway in gastric cancer.
Sukawa Y; Yamamoto H; Nosho K; Kunimoto H; Suzuki H; Adachi Y; Nakazawa M; Nobuoka T; Kawayama M; Mikami M; Matsuno T; Hasegawa T; Hirata K; Imai K; Shinomura Y
World J Gastroenterol; 2012 Dec; 18(45):6577-86. PubMed ID: 23236232
[TBL] [Abstract][Full Text] [Related]
6. A Decrease of Histone Deacetylase 6 Expression Caused by Helicobacter Pylori Infection is Associated with Oncogenic Transformation in Gastric Cancer.
He Q; Li G; Wang X; Wang S; Hu J; Yang L; He Y; Pan Y; Yu D; Wu Y
Cell Physiol Biochem; 2017; 42(4):1326-1335. PubMed ID: 28700998
[TBL] [Abstract][Full Text] [Related]
7. The Clinicopathological Features and Genetic Alterations in Epstein-Barr Virus-Associated Gastric Cancer Patients after Curative Surgery.
Fang WL; Chen MH; Huang KH; Lin CH; Chao Y; Lo SS; Li AF; Wu CW; Shyr YM
Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32531970
[TBL] [Abstract][Full Text] [Related]
8. Association between
de Souza CRT; Almeida MCA; Khayat AS; da Silva EL; Soares PC; Chaves LC; Burbano RMR
World J Gastroenterol; 2018 Nov; 24(43):4928-4938. PubMed ID: 30487702
[TBL] [Abstract][Full Text] [Related]
9. Helicobacter pylori and Epstein-Barr Virus Coinfection Stimulates Aggressiveness in Gastric Cancer through the Regulation of Gankyrin.
Kashyap D; Baral B; Jakhmola S; Singh AK; Jha HC
mSphere; 2021 Oct; 6(5):e0075121. PubMed ID: 34585958
[TBL] [Abstract][Full Text] [Related]
10. Effect of Helicobacter pylori Eradication on Long-Term Survival after Distal Gastrectomy for Gastric Cancer.
Kim YI; Cho SJ; Lee JY; Kim CG; Kook MC; Ryu KW; Kim YW; Choi IJ
Cancer Res Treat; 2016 Jul; 48(3):1020-9. PubMed ID: 26582396
[TBL] [Abstract][Full Text] [Related]
11. Clinical Significance of Epstein-Barr Virus and
Noh JH; Shin JY; Lee JH; Park YS; Lee IS; Kim GH; Na HK; Ahn JY; Jung KW; Kim DH; Choi KD; Song HJ; Lee GH; Jung HY
Gut Liver; 2023 Jan; 17(1):69-77. PubMed ID: 35611669
[TBL] [Abstract][Full Text] [Related]
12. The clinicopathological and genetic differences among gastric cancer patients with no recurrence, early recurrence, and late recurrence after curative surgery.
Chen MC; Su HY; Su YH; Huang KH; Fang WL; Lin CW; Chen MH; Chao Y; Lo SS; Fen-Yau Li A; Wu CW
J Chin Med Assoc; 2023 Jan; 86(1):57-64. PubMed ID: 36374529
[TBL] [Abstract][Full Text] [Related]
13. Association between C1019T polymorphism in the connexin 37 gene and Helicobacter pylori infection in patients with gastric cancer.
Jing YM; Guo SX; Zhang XP; Sun AJ; Tao F; Qian HX
Asian Pac J Cancer Prev; 2012; 13(5):2363-7. PubMed ID: 22901223
[TBL] [Abstract][Full Text] [Related]
14. Co-infection relationship with Epstein-Barr virus in gastroduodenal diseases with Helicobacter Pylori. Quantitative PCR and EBNA-1 gene-based approach.
Akkus S; Gareayaghi N; Saribas S; Demiryas S; Ozbey D; Kepil N; Demirci M; Ziver Snap T; Oyku Dinc H; Akcin R; Uysal O; Tugberk Bakar M; Talha Aygun M; Bahar Tokman H; Kocazeybek B
Acta Gastroenterol Belg; 2022; 85(2):301-308. PubMed ID: 35709774
[TBL] [Abstract][Full Text] [Related]
15. FAM60A, increased by Helicobacter pylori, promotes proliferation and suppresses apoptosis of gastric cancer cells by targeting the PI3K/AKT pathway.
Yao X; Liu D; Zhou L; Xie Y; Li Y
Biochem Biophys Res Commun; 2020 Jan; 521(4):1003-1009. PubMed ID: 31727367
[TBL] [Abstract][Full Text] [Related]
16. [The prognostic research of expression and relationship between Helicobacter pylori of c-met oncogene correlation with gastric mucosal proliferation].
Zhuang X; Lin S; Zheng J; Wang L; Sun G; Li Y
Zhonghua Nei Ke Za Zhi; 2001 Jun; 40(6):381-4. PubMed ID: 11798602
[TBL] [Abstract][Full Text] [Related]
17. Biological behavior of the intramucosal Helicobacter pylori-negative undifferentiated-type early gastric cancer: comparison with Helicobacter pylori-positive early gastric cancer.
Horiuchi Y; Fujisaki J; Yamamoto N; Shimizu T; Miyamoto Y; Tomida H; Taniguchi C; Morishige K; Omae M; Ishiyama A; Yoshio T; Hirasawa T; Yamamoto Y; Tsuchida T; Igarashi M; Nakajima T; Takahashi H
Gastric Cancer; 2016 Jan; 19(1):160-5. PubMed ID: 25491775
[TBL] [Abstract][Full Text] [Related]
18. Helicobacter pylori VacA-induced inhibition of GSK3 through the PI3K/Akt signaling pathway.
Nakayama M; Hisatsune J; Yamasaki E; Isomoto H; Kurazono H; Hatakeyama M; Azuma T; Yamaoka Y; Yahiro K; Moss J; Hirayama T
J Biol Chem; 2009 Jan; 284(3):1612-9. PubMed ID: 18996844
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus-associated gastric carcinomas: relation to H. pylori infection and genetic alterations.
Wu MS; Shun CT; Wu CC; Hsu TY; Lin MT; Chang MC; Wang HP; Lin JT
Gastroenterology; 2000 Jun; 118(6):1031-8. PubMed ID: 10833477
[TBL] [Abstract][Full Text] [Related]
20. Distinct Clinicopathological Features and Prognosis of Helicobacter pylori Negative Gastric Cancer.
Tsai KF; Liou JM; Chen MJ; Chen CC; Kuo SH; Lai IR; Yeh KH; Lin MT; Wang HP; Cheng AL; Lin JT; Shun CT; Wu MS;
PLoS One; 2017; 12(2):e0170942. PubMed ID: 28152027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
